BioMarin Pharmaceutical Inc
BMRN· Nasdaq
BMRNBioMarin Pharmaceutical Inc
Source filing unavailable
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $91.95M | $82.79M |
| Net Income | -$477.00K | $1.31M |
| EPS Diluted | -$0.01 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
